Special Expanded Edition Photos from the 2010 National Conference!

Fall 2010
Providing Patient
Support, Education,
& Advancing Research
Special Expanded Edition
Photos from the 2010
National Conference!
Read about the Conference
from a Patient’s Perspective 5
Cranial Electrotherapy
Stimulation:
Treating Depression
and Anxiety 6
Scientific Breakthrough:
First Animal Model for TN 7
The 512 Society
925 NW 56th Terrace, Suite C
Gainesville, FL 32605-6402
Sustaining the Future of TNA 9
ThelatestnewsbroughttoyoubyTNATheFacialPainAssociation.Presenting
informationonthecareandmanagementofneuropathicfacialpain
includingtrigeminalneuralgia.TNAservesasanadvocateforpatientsliving
withneuropathicfacialpain,includingtrigeminalneuralgia,byproviding
information,encouragingresearchandofferingsupport.
~Celebrating~
Years
1990–2010
Fall 2010
A Message from the Chairman
-RogerLevy
The highlight of TNA’s 20th Anniversary has
undoubtedly been the National Conference held
at the Mayo Clinic in Rochester, Minnesota this past
August. Our national conferences always represent the
best that TNA has to offer and this year was no exception.
First, we bring together many support group leaders and
members from across the country and then we add our
tireless and dedicated staff and Board members. Together with our Medical
Advisory Board and other speakers, we all gather to make sure that the
many patients and their loved ones who attend the conference from around
the US and from overseas learn of the latest treatments and opportunities to
deal with their pain, while enjoying the camaraderie that a shared experience
can create.
Looking back on the experience, participation in this conference
reaffirmed for me three important things. First, there is something unique
about bringing patients together with the healthcare providers who
represent best in class. Not only does this allow patients to hear from and
question experts, it allows the healthcare providers to gain insights not
readily apparent in a clinical setting. So, we will continue and expand our
conference program. Secondly, interaction among patients as they live and
learn together, if only for a few days, is an important opportunity for warding
off isolation and feelings of helplessness. This is an important opportunity
Page 1
also presented by participation in one of our support groups. And so we
must nurture and expand our support group network while encouraging
patients to become active participants. Lastly, I saw in our audience the
diversity of conditions that nerve-generated facial pain represents and that
more young people are turning to us for help. Therefore, if there was ever a
doubt whether TNA should have a role in research today, it was dispelled for
me when confronted by the impact of chronic facial pain on the young. So
we must and will expand our efforts to foster translational research for new
treatments and a cure.
With the latter in mind, the Board of TNA has created the Facial Pain
Research Foundation to raise research money and to work with multiple
institutions where finding new ways to treat facial pain are being researched.
With a separate Board of Trustees, our new Foundation will bring a novel
approach to raising funds and establishing research opportunities. I look
forward to sharing more of this as the foundation gets under way. In the
meantime, we are also re-establishing our Patient Registry as a means of
building what will be the largest database of patient facial pain information,
an important tool for researchers, to be followed by a Research Registry as a
repository for information on facial pain research projects under way across
America and overseas.
Success is a journey, not a destination, and we have a long journey before
us. But we close the year of our twentieth anniversary with rededication to
the mission and goals that the Association has set out to achieve and to the
belief that the journey will be worthwhile and that along the way the lives of
many people will be improved.
Page 2
Fall 2010
Page 3
Page 4
Fall 2010
A Patient’s Perspective on the National Conference
– Tiffany T. Smith
Today I am getting my skull opened for the second time
in one week so that electrodes stitched onto the cover of
my brain can be connected to a motor cortex stimulator
implanted in my stomach that will take away my facial pain.
That wouldn’t be happening had I not attended TNA’s
20th Anniversary National Conference last month at
the Mayo Clinic.
Three and a half years ago, at the age of 22, doctors discovered that I had sinus tumors. Many medications and
two expansive sinus surgeries later, I was left with no sinus
tumors, but something that everyone reading this article
would consider much worse: trigeminal neuralgia type
2. The constant, severe pain in the right side of my face
has hijacked what was supposed to be the best years of
my life. Instead of going out to happy hours, enjoying (or
hating!) law school, and spending time with friends, these
last several years have been a fog of doctors, emergency
room visits, medications, surgeries, and most of all, pain.
My perpetual search for answers brought me to TNA –
The Facial Pain Association’s website, and from there, I
found more detailed information about my disease. After
consulting with some of the world’s best doctors, motor
cortex stimulation was suggested as an answer to my
problems. But a year and many fights with my insurance
company later, I still had no surgery date in sight and had
not found any other successful treatment.
That all changed when I decided to attend TNA’s National
Conference. For the first time since I’ve been diagnosed,
I was surrounded by people who actually understood
my struggles. Though I’ve been lucky to have family and
friends who love and support me, there is nothing quite
like meeting other people who have been kept up at
night by the same excruciating pain as I have. I was lucky
enough to meet another young woman suffering from
Page 5
facial pain who, despite living
on opposite coasts, will probably become a lifelong friend.
On top of that, the national
conference provided me with
unparalleled access to leading doctors and researchers
for trigeminal neuralgia and
other facial pain. Instead of
having to fly across the country for limited appointments,
I attended every session I could and followed certain doctors around like a lovesick puppy. One of those doctors was
Dr. Kenneth Casey, who has become my personal hero.
After attending many of his sessions and hearing his keynote speech at the gala dinner, I decided that I had never
met a more brilliant, compassionate and dedicated doctor
and promptly informed him that I would be sending my
medical records to him as soon as I returned to Maryland. One week later, I flew to Michigan to have a formal
appointment with him, and less than two weeks after that,
I returned for motor cortex stimulation stage 1 surgery. I
am ecstatic to say that my trial was successful.
Attending the TNA conference not only served as an
introduction to the surgeon who would change my life,
but most importantly, gave me enough information to
make a thoughtful and informed decision concerning my
treatment options. I believe that attending the Conference
is imperative for anyone who suffers from facial pain, as
it provides a network of fellow patients and doctors who
– combined – are a wonderful resource for learning more
information about any type of facial pain. Unquestionably,
attending TNA’s National Conference is the best decision
I’ve ever made and has allowed me to regain the most
important thing – hope for my future.
Treating Depression and Anxiety
with Cranial Electrotherapy (CES)
- Suzanne Grenell
I have survived breast cancer – twice. I have also lived
with trigeminal neuralgia – for twelve years. As a result, I
know what it’s like to live with depression, anxiety, insomnia
and pain, and the elusive comfort offered by pharmaceutical drugs that come with a high price: serious side effects.
Having worked as a senior executive at Intel for sixteen
years, I also know how technological innovation can dramatically improve people’s lives. That’s why, when I was
introduced to Cranial Electrotherapy Stimulation or
“CES” for short, I leapt at the opportunity to test its benefits. Now, while not approved to treat facial pain, CES does
provide a drug-free treatment for depression, anxiety and
insomnia associated with all forms of chronic pain.
What exactly is Cranial Electrotherapy Stimulation? CES
works by applying a mild electrical current (so mild that it is
not felt) to the head to stimulate the brain’s production of
serotonin and dopamine, using patented radio frequencies. Serotonin and dopamine are the two neurochemicals
greatly responsible for good mood and sound sleep. The
mild electrical current is generated by a handheld device
that sends the current through two sponge applicators
on either side of the head. Some CES devices use ear clips
instead of sponges. CES devices are regulated by the FDA
and there are several varieties on the market, most of which
cost around $695. All require a prescription from a medical
practitioner licensed for electrotherapy. I have learned that
CES has been the subject of many peer reviewed studies
over the past thirty years, including research completed at
Harvard in 2009, and the overwhelming majority of studies
are positive.
I purchased my device directly from Fisher Wallace Laboratories and they were very responsive to my requests
for information and answered my questions promptly.
But there are several devices on the market and, as with
all treatments, you need to check out CES before you try
it, as CES may not be for everyone. However, it is helping
me. With it, I am moving forward on a continuous path of
health improvement and balance in my life and I encourage
anyone with chronic pain to consider it as an alternative
to drugs.
Editor’s Note: Suzanne is a former TNA Board member and is a
frequent speaker on wellness issues. TNA does not endorse any particular treatment, product or service. However, we believe that facial
patients can benefit from the personal experiences of others.
Providing Patient Support, Education, and Advancing Research
925 NW 56th Terrace, Suite C
Gainesville, FL 32605-6402
Tel.: 1.800.923.3608 or 352.331.7009
www.tna-support.org
Page 6
Fall 2010
In Florida Laboratory: Scientists
Aim to Develop First Animal
Model of Trigeminal Neuralgia
– Arline Phillips-Han
University of Florida neuroscientist Lucia Notterpek,
PhD, is leading major new studies in mice aimed
at developing an animal model of the human pain
associated with damage to the myelin sheath, which
electrically insulates nerves. Her research, funded by The
TNA-Facial Pain Association, addresses fundamental
questions about the role of myelin deterioration
in trigeminal neuralgia (TN), and involves testing
experimental drugs to repair the damage.
“At the present stage of research into trigeminal
neuralgia, the focus needs to be on the myelin* sheath,”
says Albert Rhoton Jr., MD, the father of modern-day
microscopic neurosurgery and internationally known
teacher, brain anatomist and textbook writer at the UF
McKnight Brain Institute. “Surgical treatment has
been relatively static for 25 years or so, and medications
have advanced minimally. Today, no available drug is
much better than Tegretol.” (Tegretol is the brand
name for the drug carbamezepine, the frontline
treatment for facial pain.)
Rhoton, who treated more than 3,000 patients with
trigeminal neuralgia during his 40 years of clinical
practice, says many experts on this nerve disorder
believe the notoriously intense and often disabling
TN pain is initiated by myelin damage, which occurs
when an artery or vein sags and pulsates against the
trigeminal nerve. In many cases of typical TN, this
theory seems verified surgically; many TN patients
Page 7
find great pain relief when a surgeon separates the
offending blood vessel from the nerve. But thousands
of patients who suffer with facial pain do not respond
to any available therapy.
Rhoton says there is evidence, seen though the
surgical microscope, of indentations in the trigeminal
nerve at places where the myelin appears thinned or
notched. He said one line of thinking is that the myelin
sheath tries, but fails, to regenerate itself after injury,
underscoring the need for expanded research.
Notterpek, who chairs the Department of
Neuroscience at UF, has rapidly established her
project. She is now using mice to test one wellknown nerve-protective molecule and several newly
developed pharmaceutical compounds designed to
stabilize the myelin-producing Schwann cells. The
animals undergoing treatment include mice with
various myelin abnormalities, as well as mice that lack
the myelin-producing gene known as PMP22, and
mice with healthy myelin.
Prior to administering the drug compounds, myelin
damage is induced in anesthetized mice by tying
surgical thread around the trigeminal nerve, an attempt
to replicate the kind of nerve-compression injury
associated with classic TN. The animals are then tested
at regular intervals to correlate myelin damage with
behavioral changes that appear to indicate discomfort.
Testing the animals for “pain” is a special assignment
for Andrew Ahn, MD, PhD, a neurologist with
expertise in headache and facial pain recently recruited
to the UF College of Medicine from the University of
California San Francisco.
“Whether what we measure in the mice is actually
the same as the pain in our patients is uncertain, but
we make our best approximation through a series
of behavioral approaches aimed at analyzing their
sensitivity to various stimuli,” said Ahn, an assistant
professor of neurology and neuroscience. “We start with
observations of how the mice behave spontaneously;
concerted grooming behaviors over the affected area
can be suggestive of pain or discomfort. Then we can
look at how they respond (for example by flinching)
to touch with a calibrated mechanical stimulus using
so-called von Frey hairs that look like a short segment
of fishing line on the end of a short handle, and to
various levels of heat. In a newer approach believed to
be more clinically relevant, we are assessing changes
in operant behavior, or how pain might interfere
with motivated activities such as eating or drinking.
Ahn and Notterpek are collaborating with a large
group of scientists associated with the UF College
of Dentistry’s Comprehensive Center for Pain
Research, one of few such centers in the nation.
Notterpek has published two papers on her
discovery that rodents generally have to reach a certain
age before they show signs of myelin deterioration—
similar to the way TN most often affects people over
age 50.
She is testing a hypothesis that the peripheral nerves
in mice with PMP22 gene deficiency are more sensitive
to injury, and require little provocation to initiate
myelin damage, as compared to normal mice. She
aims to determine the least amount of nerve damage
required to initiate loss of myelin in normal mice, and
in mice that are deficient in the PMP22 gene. At the
close of each study, the mice are sacrificed so that
the trigeminal nerve can be removed and examined
microscopically to assess the status of the myelin
coating. The scientists remove the peripheral facial
nerves and measure the level of molecules involved in
both the myelin sheath pathway and the pain pathway.
“We have selected small compounds that could be
given orally to human patients, once we establish a
safe dosage and rule out unacceptable side effects,”
Notterpek said. Obtaining reliable data will require
repeated experiments in large numbers of animals,
which could take several years.
Douglas K. Anderson, PhD, Eminent Scholar
Emeritus in Neuroscience at UF, who preceded
Notterpek as chairman of the Department of
Neuroscience, proposes another approach to myelin
repair that might be tested in the kind of myelindeficient animal model she is developing.
Anderson suggests the demyelinated region of
the trigeminal nerve might be patched with myelinproducing cells derived from adult or embryonic stem
cells, or with the patient’s own Schwann cells, provided
these cells do not carry a genetic defect that produces
unstable myelin.
“Fixing this ‘short circuit’ on the trigeminal nerve
could restore normal or near normal activity in this
nerve and eliminate the debilitating episodes of pain,”
he said. He also speculates “gene therapy might be
used to deliver genes that produce endogenous
factors known to control pain, and/or to knock out
genes found to be involved in pain production. With
this approach, it might be possible to manage the pain
(CONTINUED ON PAGE 10)
Page 8
Fall 2010
512 Society Campaign Launches
Macaroni & Cheese
As part of ensuring its future, TNA The Facial Pain
Association successfully launched a campaign at
the national conference in August to create and
sustain a future for the organization. The gifts of
512 people driven to create a future for TNA will
make a million-dollar endowment a reality.
Is there a better comfort food than Mac ‘n Cheese? Here is a
basic recipe with a few suggested twists.
• 8 T. (1 stick) unsalted butter
• 6 slices good white bread, crusts removed,
torn into ¼ to ½ inch pieces
• 5 ½ C milk
• ½ C flour
• 2 tsp. salt
• ¼ tsp. freshly grated nutmeg
• ¼ tsp. freshly ground black pepper (optional)
• 4 ½ C grated sharp white cheddar
• 2 C grated Gruyere or 1 ¼ C grated Pecorino Romano cheese
• 1 lb. elbow macaroni
The campaign goal is to enlist 512 people willing to share the vision as charter members by
donating $2,000 each over the next two years. The
million-dollar endowment will lay a solid foundation for sustaining and expanding TNA services
to facial pain patients and their families, as well
as the healthcare professionals at the frontline
of diagnosis and treatment. Earnings generated
from investment of the endowment also will yield
seed money to support new initiatives aimed at
improving the lives of all who endure the debilitating pains of trigeminal neuralgia and other
neuropathic facial pains.
As TNA moves forward with the 512 Society
legacy campaign, the plans are to continue to
promote the campaign throughout the country
and bring exclusivity to the 512 Society providing
additional benefits of joining and national recognition of all members who have chosen to invest
in TNA and share the vision. More information
about the 512 Society can be obtained by calling
the National Office at 1-800-923-3608 or email
Susan Cupp, Chief Executive Officer, at scupp@
tna-support.org.
Leave your legacy; join the 512 Society today!
Page 9
Charter Members of the 512 Society
as of this publication date:
Anonymous Members (7)
John F. Alksne, MD
Linda Lee Alter
Ramesh P. Babu, MD
Nicholas M. Barbaro, MD
Eden S. Blair, PhD
John F. Boettner
Michael Brisman, MD
Nell and Truman Channell
James and Mary Draeger
Peter J. Jannetta, MD
Roger L. Levy, Esq.
Gwender Lias-Baskett
Mark E. Linskey, MD
Richard Marschner
Franklin J. Naivar
Michael Pasternak, PhD
Jean C. Raymond
Raymond F. Sekula, Jr., MD
Konstantin Slavin, MD
Lisa and Paul Smith
Ms. L. Sunderland-Klassen
John M. Tew, Jr., MD
Kenneth White
Mary Zalepeski
Richard S. Zimmerman, MD
Preheat oven to 375°. Butter a 3-quart casserole dish; set aside.
Place bread in a medium bowl. Melt 2 T. butter, pour melted
butter over bread, toss and set aside.
Cover a large pot of water and bring to boil. Cook the macaroni
until the outside of pasta is cooked and the inside is underdone,
2 to 3 minutes. Transfer macaroni to a colander and drain well.
Warm milk in a saucepan over medium heat. Melt remaining
butter in a high-sided skillet. When butter bubbles, add flour.
Cook, whisking, 1 minute. Slowly add hot milk a little at a time
to keep mixture smooth. Continue cooking, whisking constantly,
until mixture bubbles and thickens, 8 to 12 minutes.
Remove pan from heat. Stir in salt, nutmeg, pepper, 3 cups
cheddar, 1 ½ cups Gruyere or Pecorino. Fold macaroni into the
cheese sauce. Pour mixture into prepared baking dish.
Sprinkle remaining cheese and bread crumbs over top. Bake
until golden, about 30 minutes. Serves 8.
Twist #1: Melt 2 T butter, add ½ lb. Cremini mushrooms and ½
lb. Shiitake mushrooms, stems removed, caps sliced. Sauté until
tender, add 3 T cream sherry, continue to sauté until sherry is
absorbed. Add mushrooms to cheese and macaroni mixture, bake.
Twist #2: Replace ½ C of Gruyere with ½ C of crumbled blue
cheese and add 6 slices of crisp, crumbled bacon to cheese and
macaroni mixture, bake.
Twist #3: Add 2 lbs. of cooked lobster meat to cheese and
macaroni mixture, bake.
SAVE THE DATE!
TNA Conference Schedule for 2010 -2011
New Orleans, Louisiana....... April 2011
Richmond, Virginia................ May 2011
Irvine, California..................... Sept. 2011
Animal Model: Continued from Page 8
of TN without actually repairing, or even identifying, the
defect producing the pain.”
Anderson says investigation of demyelination in mice
also may lead to better understanding of other nervedegenerative diseases such as multiple sclerosis, in which
damage to the myelin disrupts normal transmission of
nerve impulses. This common link of myelin injury gives
strong rationale for the development and validation of an
animal model as a number one priority toward the development of effective therapy that will reverse or stop the
progression of trigeminal neuralgia.
Anderson previously served on the TNA-FPA Board of
Directors and was instrumental in drafting the blueprint for
the research initiative led by Notterpek. He is internationally known in scientific circles for his development of the
first effective medication for acute spinal cord injury and
for his pioneering studies of embryonic tissue transplants
to halt complicated wounds associated with paralyzing
spinal cord injury in people.
Keep up with research briefings on the TNA-FPA web
site at http://www.tna-support.org.
* Myelin is an electrically insulating coating on nerve fibers. It
helps to increase the speed at which impulses are conducted along
the nerve and to prevent the electric current from leaving the axon
of the nerve. Myelin can be damaged by a tumor or an overlying
blood vessel.
Page 10
Fall 2010
TNA – The Facial Pain Association Welcomes New Members
July 2010
The following individuals joined or renewed their TNA membership between April & September 2010.
Judi Coleman
Kittie Robertson
Richard Fishman
Anne Masterson
Evelyn Burry
Philip Tereskiewicz
Diane Mosbrucker
Carol Belluomo
Maura Nolan
Vicki Jankowski
Nyda Concialdi
Delores H. Zimmerman
Danielle Lavoie
Nancy L Cowger
Michael Eckman
Lynn Ruppe
Candy Schoeneberg
Ella Burakowski
Vince Holtmann
Judy Osborne
Virginia Masse
Mary Gregerson
Harold Buder
Lee Alloway
Judith Chodil
Sharon Raphael
Rita Welz
Elizabeth Rash
Kathleen Brown
Sharon Groten
John & Rosemary Ashby
Shelba-Jean Fricks
Luella LaBrant
Cynthia Bordan
Grant Reibelt
John Hartigan
Jacquie Roland
LaVonne Gerdes
Victoria Hartmann
John Temple
Brian Power
Howard buchly
Sharon Hamilton
April 2010
May 2010
Brenda Sharp
Clarence Willard
Barbara Haskins
Karen Hopwood
Susan Berrodin
Ronald Irons
Angela Sorensen
Mary E Stanley
Patty Biringer
Steven Zimmerman
Jerrie Fowler
Ted Wozny
Roger W. Dobson
Christy Bosak
Kathleen Gallivan
Sue Vincent
Silke Baumann
Anne Leskinen
Jacqueline Moody
Jerri Griffee
Peter A. Robertson, Jr.
Tom Bailey
Charles Webster
Doreen VanMinsel
Wesley Allen
Debbie Barker
Sarah Goldberg
Betty Hare
Tiffanie Rosier
Beatrice Figueroa
Theral Moore
Gwenne Cicero
Paul Milton
Peter Costantino
Angelina Olsen
William Siebrandt
Jerry Renninger
Jennifer Sonnenberg
Carolyn Vasquez
Tim Moore
Chuck Brandt
Yifu Zhu
Ann Clayton
Aimee M. Kerkemeyer
Reba Little
Lauren Senese
Barbara Omoth
Ronald Streich
Paul Selman
Sharon Jo Bramm
Virginia Fugate
Betty Luckett
Phil and Carol Muller
Yvette Kalb
Mary Swift
M.D. Weeks
Linda Collier
Joseph Martin
Patricia Ramsey
Patricia D’Ambrosio
Bonnie G. Gray
Steve Callanan
Kathleen Reid
Douglas Stone
Amy Elliott
Joyce Sternberg
Andrea Ashe
Susanne Eberle
Beverly Sherbondy
Edward Welty
Andrew Petitjean
Richard Tedford
Mary Jane Pych
Veronica Rone
Laura Luca
Claire R. Hughes
Barbara Travis
Shirley Dean
Mary Parks
Floria Cardona
Page 11
Lynne Hales
Michael Ramirez
Jimmy Brown
Danette McGee
Darlene & Ric Knorr
W. J. Wright
Mike Taylor
Lynda Ketcham
Kim Trelegan
Barbara Frazier
Elizabeth Gale
Rose Rich
Jennifer Sweeney
Robert Alexander
Sarah Cohen
June 2010
Linda Hokit
Cynthia Bennett
Angie Keppel
Vickie Dance
Michael Pasternak
Christine Falco
Lilly Glass
Rennee DeTullio
Thomas Bowler
Bob Moses
Barbara Rappaport
Monica Laust
Crissy Ortiz
Joanne Thompson
Dale Richardson
Pearl Schulson
Jean Lumpkin
Judy Folkmanis
Sam Briscoe
Kathleen Warren
Gwen Lias- Baskett
Dorothy Erwin
Pat Dought
Jerry Shain
Wesley Bezuidenhout
jodi kinmon
Barbara Daniels
Diane Antonette
Tiffany Smith
Neal Kratzke
Gene Summerville
Karen Schroeder
Erika Sanchez
Phyllis Ogof
Janice Przystal
Janice Revelos
Linda Park
Virginia Frazier
Judy Bedford
Joyce Clark
Marie Kulp
James Walker
Maria Miller
Ellen Harris
Karen C. Hopwood
Glen Damron
Dan Merges
Robert Parsons
Lisa Eschleman
Kathryn Rosenblatt
Rosemary Walter
Gwen Lias Baskett
Judith B. Friedman
Roy Crane
LeRoy Nelson
Diane Hoffman
Manuela & Calvin Noel
Nancy Oscarson
Judy Scheiwe
Sylvia R. Schoenfeld
James Mullins
Jenenne M Thompson
Elda Mueses
Ditslear Janet
Lynn Lorenz
Brent Clyde
Lisa Single
Leonard Abrams
Karis Boerner
Mary E. Johnson
Shelley Kothlow
Rhonda Furin
Katherine Strotman
Norma Murray
Stephen Iacovino
Pamela Clifford
Frank Krone
David Yost
Ilean Wesley
Lisa Coffman
Stephanie Fisher
libuse carosella
Joanne Kimsey
Shannon Ross
Marion Conditt
Kip (Denise) Benko
Patricia Parenti
Norman Peters
Laura Dabrowski
Dana Strothman
Margaret Glass
Gloria Johnson
Suzanne LaVoie
August 2010
Gregory Strain
Alice Norris
Thomas Houle
Karin Woeste
Trudi McDonald
Frances Schimandle
Alan Stumbaugh
Harry Nutter
Susan Serrapere
Mary Healy
Marilyn Thayer
Frank Skoviera
Carolyn Churchwell
Dwight Jundt
Susan Folchi
Melinda Melvin
Susan Anderson
Kimberly Liedberg
Douglas Blake
Efstathios Dourdounas
Charlcie Montgomery
Deidre M Silbert
Stephen Davis
Lisa Free
Kathleen Kennedy
Steffany Catalano
Michael DeJarnette
Carol Sluzevich
David Sirois
Darlene Troxel
John Albrecht
Eldon Christians
Alfreda Willingham
Mary Draeger
Tracey Belden
Carolyn Krinkie
Ken Hassel
Scott Bergh
Elaine Schneider
Roberta Boyle
Eileen Post
Matthew ORourke
September 2010
Charlotte McLaughlin
Mark Linskey, MD
Norah Rodgers
Sara Bentley Wierda
Kelley Bergman
Li-lan
Maureen Walsh
Pam Kubala
Barbara Farmer
Estelle Rubenstein
Joan Piasecki
Darlene Linhart
Larry Mengedoht
Rathna Lingamaneni
Allan Waxman
Merle McCartney
Suzanne Donnelly
Jason Cable
Abby Semel
Julene Sommers
Natalie Schickling
Jim Dowdy
Tamarah Haywood
Roy McKay
Judith Martin
Robert Krinkie
Fredy Argir
Larry Druffel
Earnest Najorka
Marina Barreras
Gwen Asplundh
Nancy Jones
Allison Blevins
Belinda Lijeron
Karen Downing
Rita Ratliff
Jitka Karlikova
Mariana Carlstrom
Minnie Wright
Rajesh Bindal
Maureen OConnor
Jody Eff
Jane Bryant
Hillary Collier
Starr Oliver
Anne Goldberg
Kathleen McGetrick
Brenda Weddle
Monica Jaramillo
Philip Einhorn
Vickie Guite
Theresa Cole-McCabe
Barbara Shavulsky
Paul Bracaglia
Chris Loughran
Barbara Babbitt
Soraya Namvar
Page 12